We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$26.1M
2
RTN
Raytheon Company
RTN
+$22.2M
3
ABT icon
Abbott
ABT
+$20.8M
4
ELLI
Ellie Mae Inc
ELLI
+$19.9M
5
BURL icon
Burlington
BURL
+$19.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWR icon
376
iShares Russell Mid-Cap ETF
IWR
$56.8B
$648K 0.01%
14,880
– –
KKR.PRA
377
DELISTED
KKR & Co. Inc. 6.75% Series A Preferred Units
KKR.PRA
$646K 0.01%
+23,853
New +$644K
BSTC
378
DELISTED
BioSpecifics Technologies Corp.
BSTC
$642K 0.01%
14,057
-15
-0.1% -$602
PH icon
379
Parker-Hannifin
PH
$125B
$639K 0.01%
5,088
– –
PRLB icon
380
Protolabs
PRLB
$1.86B
$639K 0.01%
10,660
+165
+2% +$9.49K
BP icon
381
BP
BP
$113B
$638K 0.01%
21,580
+910
+4% +$26.4K
GEK.CL
382
DELISTED
General Electric Capital Corp.
GEK.CL
$637K 0.01%
+24,736
New +$654K
HES
383
DELISTED
Hess
HES
$635K 0.01%
11,845
-255
-2% -$13.7K
TAL icon
384
TAL Education Group
TAL
$5.71B
$630K 0.01%
53,328
+8,796
+20% +$92.8K
FMBI
385
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$618K 0.01%
31,946
– –
FITB
386
Fifth Third Bancorp
FITB
$52B
$606K 0.01%
29,595
-800
-3% -$15.4K
ICPT
387
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$604K 0.01%
+3,670
New +$579K
HTGC icon
388
Hercules Capital
HTGC
$2.94B
$601K 0.01%
+44,345
New +$591K
BGB
389
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
$597K 0.01%
40,000
+10,437
+35% +$154K
NFLX icon
390
Netflix
NFLX
$292B
$584K 0.01%
59,250
+3,930
+7% +$37.5K
AXS icon
391
AXIS Capital
AXS
$8.59B
$583K 0.01%
10,724
– –
NTRS icon
392
Northern Trust
NTRS
$22.2B
$583K 0.01%
8,573
-100
-1% -$6.79K
MFA
393
MFA Financial
MFA
$929M
$577K 0.01%
+19,282
New +$585K
EMN icon
394
Eastman Chemical
EMN
$7.8B
$576K 0.01%
8,506
-354
-4% -$23.8K
PNY
395
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$576K 0.01%
9,600
– –
SMCI icon
396
Super Micro Computer
SMCI
$19.5B
$570K 0.01%
243,940
-27,900
-10% -$62.1K
TXN icon
397
Texas Instruments
TXN
$255B
$561K 0.01%
7,997
-217
-3% -$14.8K
DDC
398
DELISTED
Dominion Diamond Corporation
DDC
$553K 0.01%
56,790
+1,630
+3% +$14.6K
LMT icon
399
Lockheed Martin
LMT
$134B
$548K 0.01%
2,285
+80
+4% +$20K
GGP
400
DELISTED
GGP Inc.
GGP
$541K 0.01%
19,600
– –
14 15
16
17 18

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.